INS and diabetes mellitus: In our study, patients treated with OADs had a similar reduction in hbA1c from baseline compared to those with OAD plus insulin, providing evidence that an anti‐DM regimen consisting only of OAD can be a safe alternative in patients who are reluctant to use insulin.